Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2015 (← Previous) (Next →)
Filing Date: Nov 16, 2015
Total Value: $626M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 1,685,719 | $41.13M | 6.6% | $15.53 | +114.6% | COM | 427746102 |
| ALKS | ALKERMES PLC | 700,000 | $41.07M | 6.6% | $56.67 | +16.5% | SHS | G01767105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 718,900 | $28.61M | 4.6% | $15.30 | +216.0% | COM | 64125C109 |
| — | DYAX CORP | 1,400,000 | $26.73M | 4.3% | $11.07 | — | COM | 26746E103 |
| ARDX | ARDELYX INC | 1,481,075 | $25.59M | 4.1% | $17.63 | +5.9% | COM | 039697107 |
| — | ALDER BIOPHARMACEUTICALS INC | 757,475 | $24.82M | 4.0% | $41.16 | — | COM | 014339105 |
| EGRX | EAGLE PHARMACEUTICALS INC | 300,000 | $22.21M | 3.5% | $20.11 | +313.7% | COM | 269796108 |
| OMER | OMEROS CORP | 1,960,000 | $21.48M | 3.4% | $15.02 | +3.6% | COM | 682143102 |
| — | PORTOLA PHARMACEUTICALS INC | 500,000 | $21.31M | 3.4% | $27.49 | — | COM | 737010108 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,095,334 | $17.58M | 2.8% | $9.16 | +73.9% | COM NEW | 83587F202 |
| — | QUOTIENT LTD | 1,119,100 | $14.55M | 2.3% | $13.68 | — | SHS | G73268107 |
| — | DYNAVAX TECHNOLOGIES CORP | 575,000 | $14.11M | 2.3% | $23.57 | — | COM NEW | 268158201 |
| DXCM | DEXCOM INC | 153,000 | $13.14M | 2.1% | $7.91 | +181.9% | COM | 252131107 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1,080,000 | $12.31M | 2.0% | $11.03 | +21.0% | COM | 09058V103 |
| — | NEVRO CORP | 265,386 | $12.31M | 2.0% | $51.69 | — | COM | 64157F103 |
| — | TESARO INC | 291,250 | $11.68M | 1.9% | $38.73 | — | COM | 881569107 |
| CHRS | COHERUS BIOSCIENCES INC | 569,130 | $11.4M | 1.8% | $20.98 | +45.1% | COM | 19249H103 |
| — | NOVAVAX INC | 1,600,000 | $11.31M | 1.8% | $6.35 | — | COM | 670002104 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 140,000 | $11.25M | 1.8% | $119.50 | -7.0% | COM | 02043Q107 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 109,500 | $10.55M | 1.7% | $50.99 | +124.5% | COM | 90400D108 |
| — | SAGE THERAPEUTICS INC | 240,000 | $10.16M | 1.6% | $42.32 | — | COM | 78667J108 |
| — | CHINA BIOLOGIC PRODS INC | 111,500 | $10.02M | 1.6% | $66.66 | — | COM | 16938C106 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 450,000 | $9.95M | 1.6% | $17.29 | +4.1% | COM | 19459J104 |
| — | RECRO PHARMA INC | 780,000 | $9.383M | 1.5% | $7.16 | — | COM | 75629F109 |
| — | PFENEX INC | 624,900 | $9.38M | 1.5% | $16.77 | — | COM | 717071104 |
| — | MIRATI THERAPEUTICS INC | 255,000 | $8.777M | 1.4% | $34.42 | — | COM | 60468T105 |
| — | ROCKWELL MED INC | 1,105,000 | $8.52M | 1.4% | $9.23 | — | COM | 774374102 |
| — | ADVAXIS INC | 800,000 | $8.184M | 1.3% | $7.24 | — | COM NEW | 007624208 |
| — | FORWARD PHARMA A/S | 335,068 | $7.894M | 1.3% | $23.83 | — | SPONSORED ADR | 34986J105 |
| — | LIPOCINE INC NEW | 666,666 | $7.887M | 1.3% | $6.90 | — | COM | 53630X104 |
| — | SERES THERAPEUTICS INC | 250,000 | $7.41M | 1.2% | $32.01 | — | COM | 81750R102 |
| — | AGENUS INC | 1,559,000 | $7.171M | 1.1% | $4.54 | — | COM NEW | 00847G705 |
| — | MINERVA NEUROSCIENCES INC | 1,145,043 | $6.011M | 1.0% | $5.16 | — | COM | 603380106 |
| — | REGULUS THERAPEUTICS INC | 896,522 | $5.863M | 0.9% | $14.62 | — | COM | 75915K101 |
| — | CURIS INC | 2,632,000 | $5.317M | 0.8% | $2.28 | — | COM | 231269101 |
| — | ZYNERBA PHARMACEUTICALS INC | 356,600 | $5.103M | 0.8% | $14.31 | — | COM | 98986X109 |
| — | ACCELERON PHARMA INC | 200,000 | $4.98M | 0.8% | $32.04 | — | COM | 00434H108 |
| — | ATARA BIOTHERAPEUTICS INC | 150,000 | $4.716M | 0.8% | $38.55 | — | COM | 046513107 |
| — | APTOSE BIOSCIENCES INC | 1,081,867 | $4.713M | 0.8% | $5.91 | — | COM NEW | 03835T200 |
| — | INTEC PHARMA LTD JERUSALEM | 800,000 | $4.48M | 0.7% | $5.60 | — | SHS | M53644106 |
| — | NEKTAR THERAPEUTICS | 397,500 | $4.357M | 0.7% | $12.07 | — | COM | 640268108 |
| — | DERMIRA INC | 170,000 | $3.968M | 0.6% | $18.11 | — | COM | 24983L104 |
| — | EPIRUS BIOPHARMACEUTICALS INC | 896,600 | $3.963M | 0.6% | $8.68 | — | COM | 29428P107 |
| — | ARRAY BIOPHARMA INC | 850,000 | $3.876M | 0.6% | $5.01 | — | COM | 04269X105 |
| — | KITE PHARMA INC | 68,800 | $3.831M | 0.6% | $46.23 | — | COM | 49803L109 |
| RGNX | REGENXBIO INC | 156,741 | $3.453M | 0.6% | $25.52 | 0.0% | COM | 75901B107 |
| — | EPIZYME INC | 266,250 | $3.424M | 0.5% | $18.78 | — | COM | 29428V104 |
| — | KARYOPHARM THERAPEUTICS INC | 300,987 | $3.169M | 0.5% | $33.09 | — | COM | 48576U106 |
| — | CELYAD SA | 75,000 | $3.139M | 0.5% | $52.03 | — | ADR | 151205200 |
| — | LION BIOTECHNOLOGIES INC | 499,815 | $2.879M | 0.5% | $11.67 | — | COM | 53619R102 |
| — | GENVEC INC | 1,176,235 | $2.717M | 0.4% | $2.65 | — | COM NEW | 37246C307 |
| — | TETRALOGIC PHARMACEUTICALS C | 5,000,000 | $2.647M | 0.4% | $0.60 | — | NOTE 8.000% 6/1 | 88165UAB5 |
| — | ACELRX PHARMACEUTICALS INC | 850,000 | $2.593M | 0.4% | $9.56 | — | COM | 00444T100 |
| — | GLYCOMIMETICS INC | 458,955 | $2.57M | 0.4% | $16.33 | — | COM | 38000Q102 |
| — | IMMUNE DESIGN CORP | 189,000 | $2.306M | 0.4% | $18.77 | — | COM | 45252L103 |
| — | OVASCIENCE INC | 252,180 | $2.141M | 0.3% | $25.13 | — | COM | 69014Q101 |
| — | BLUEPRINT MEDICINES CORP | 100,000 | $2.134M | 0.3% | $26.49 | — | COM | 09627Y109 |
| — | AQUINOX PHARMACEUTICALS INC | 150,000 | $2.111M | 0.3% | $12.15 | — | COM | 03842B101 |
| FOLD | AMICUS THERAPEUTICS INC | 150,000 | $2.099M | 0.3% | $12.02 | +30.5% | COM | 03152W109 |
| SGMO | SANGAMO BIOSCIENCES INC | 361,000 | $2.036M | 0.3% | $17.13 | -51.9% | COM | 800677106 |
| — | CERULEAN PHARMA INC | 551,354 | $2.018M | 0.3% | $5.47 | — | COM | 15708Q105 |
| — | DICERNA PHARMACEUTICALS INC | 245,000 | $2.011M | 0.3% | $15.70 | — | COM | 253031108 |
| — | VERSARTIS INC | 170,000 | $1.96M | 0.3% | $28.04 | — | COM | 92529L102 |
| — | AVEO PHARMACEUTICALS INC | 1,587,715 | $1.921M | 0.3% | $1.74 | — | COM | 053588109 |
| — | KINDRED BIOSCIENCES INC | 328,497 | $1.708M | 0.3% | $11.93 | — | COM | 494577109 |
| — | QUOTIENT LTD | 500,000 | $1.63M | 0.3% | $3.26 | — | *W EXP 10/30/201 | G73268123 |
| — | HTG MOLECULAR DIAGNOSTICS IN | 201,000 | $1.532M | 0.2% | $11.15 | — | COM | 40434H104 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $1.265M | 0.2% | $0.82 | -37.2% | COM | 74373P108 |
| — | AGILE THERAPEUTICS INC | 182,053 | $1.227M | 0.2% | $8.82 | — | COM | 00847L100 |
| — | PRONAI THERAPEUTICS INC | 53,153 | $1.091M | 0.2% | $20.53 | — | COM | 74346L101 |
| ASND | ASCENDIS PHARMA A S | 61,500 | $1.089M | 0.2% | $17.35 | — | SPONSORED ADR | 04351P101 |
| — | NEOS THERAPEUTICS INC | 50,000 | $1.051M | 0.2% | $21.02 | — | COM | 64052L106 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $1.044M | 0.2% | $2.22 | — | COM NEW | 15117F203 |
| — | CONTRAFECT CORP | 234,406 | $1.043M | 0.2% | $5.25 | — | COM | 212326102 |
| AKBA | AKEBIA THERAPEUTICS INC | 100,300 | $969K | 0.2% | $24.08 | -61.9% | COM | 00972D105 |
| — | SCYNEXIS INC | 99,366 | $723K | 0.1% | $8.02 | — | COM | 811292101 |
| — | AKARI THERAPEUTICS PLC | 28,650 | $687K | 0.1% | $23.98 | — | SPONSORED ADR | 00972G108 |
| — | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $686K | 0.1% | $0.22 | — | *W EXP 06/24/202 | 74373P116 |
| GALT | GALECTIN THERAPEUTICS INC | 286,200 | $670K | 0.1% | $13.23 | -82.2% | COM NEW | 363225202 |
| — | BIOTIE THERAPIES OYJ | 50,000 | $655K | 0.1% | $19.98 | — | SPONSORED ADR | 09074D103 |
| VCYT | VERACYTE INC | 137,990 | $647K | 0.1% | $7.94 | +19.9% | COM | 92337F107 |
| — | NANOSTRING TECHNOLOGIES INC | 40,000 | $640K | 0.1% | $20.65 | — | COM | 63009R109 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $451K | 0.1% | $0.60 | — | *W EXP 08/19/201 | 15117F112 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 25,000 | $299K | 0.0% | $18.32 | — | SPONDS ADR | 00653A107 |
| CLLS | CELLECTIS S A | 11,300 | $298K | 0.0% | $34.60 | — | SPONSORED ADS | 15117K103 |
| — | APPLIED GENETIC TECHNOL CORP | 17,110 | $225K | 0.0% | $23.10 | — | COM | 03820J100 |
| — | HERON THERAPEUTICS INC | 5,000 | $100K | 0.0% | $20.00 | — | CALL | 427746902 |